Oncology News | pharmaphorum

News

Patients in England with a rare form of eye cancer will be able to access Kimmtrak, a TCR therapy from Immunocore, after NICE changes its position.

News

Faced with a cash crunch, Alligator Biosciences has said it plans to shed up to 70% of its workforce.

News

Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma

News

Kelun-Biotech has become the second drugmaker to bring a TROP2 ADC to regulatory approval, after its sac-TMT drug was cleared in China

News

Novartis' fast-growing breast cancer drug gets another growth driver as EU approves adjuvant use in patients with early-stage HR+, HER2- tumours

News

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline